Previous 10 | Next 10 |
Cogent Biosciences to Present Virtually at Jefferies London Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , Nov. 2, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on dev...
Cogent Biosciences Presents New Preclinical Data Demonstrating Bezuclastinib as a Differentiated KIT Inhibitor with Minimal Brain Penetration Currently enrolling APEX, a Phase 2 clinical study of bezuclastinib (CGT9486) for patients with Advanced Systemic Mastocytosis (AdvSM) ...
Cogent Biosciences to Present Preclinical Data on Bezuclastinib at AACR-NCI-EORTC Conference PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , Oct. 1, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused ...
Cogent Biosciences (NASDAQ:COGT): Q2 GAAP EPS of -$0.43 misses by $0.07. As of June 30, 2021, company had cash and cash equivalents of $218.1M. Press Release For further details see: Cogent Biosciences EPS misses by $0.07
Cogent Biosciences Provides Corporate Updates and Reports Second Quarter 2021 Financial Results Initiated Phase 2 open-label clinical study (APEX) for bezuclastinib (CGT9486) in patients with Advanced Systemic Mastocytosis (AdvSM) SUMMIT study for patients with Non-Advanced ...
Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , July 27, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on deve...
syahrir maulana/iStock via Getty Images Cogent Biosciences ([[COGT]] +0.5%) has received the FDA’s Orphan Drug Designation for a treatment targeted at gastrointestinal stromal tumors ((GIST)). GISTs making up less than 1% of all gastrointestinal tumors affect about ...
Cogent Biosciences to Present at Ladenburg Thalmann Virtual Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , June 29, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on develo...
Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , May 26, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision ...
Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results IND cleared for Phase 2 study of CGT9486, a selective mutant KIT inhibitor, in Advanced Systemic Mastocytosis patients John Robinson, PhD appointed as Chief Scientific Officer to l...
News, Short Squeeze, Breakout and More Instantly...
Cogent Biosciences Inc Com Company Name:
COGT Stock Symbol:
NASDAQ Market:
Cogent Biosciences Inc Com Website:
2024-07-06 14:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
WALTHAM, Mass. and BOULDER, Colo., June 27, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced it has reached alignment with the U.S. Food and Drug Admin...
2024-06-26 16:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...